These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 30445661)

  • 1. The involvement of microglia in Alzheimer's disease: a new dog in the fight.
    Moore Z; Taylor JM; Crack PJ
    Br J Pharmacol; 2019 Sep; 176(18):3533-3543. PubMed ID: 30445661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets.
    Nizami S; Hall-Roberts H; Warrier S; Cowley SA; Di Daniel E
    Br J Pharmacol; 2019 Sep; 176(18):3515-3532. PubMed ID: 30740661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Don't forget astrocytes when targeting Alzheimer's disease.
    Sadick JS; Liddelow SA
    Br J Pharmacol; 2019 Sep; 176(18):3585-3598. PubMed ID: 30636042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutics for dementia and Alzheimer's disease: New directions for precision medicine.
    Duce JA; Zhu X; Jacobson LH; Beart PM
    Br J Pharmacol; 2019 Sep; 176(18):3409-3412. PubMed ID: 31468515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating Alzheimer's disease by targeting iron.
    Nikseresht S; Bush AI; Ayton S
    Br J Pharmacol; 2019 Sep; 176(18):3622-3635. PubMed ID: 30632143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities.
    Perez Ortiz JM; Swerdlow RH
    Br J Pharmacol; 2019 Sep; 176(18):3489-3507. PubMed ID: 30675901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues.
    Ittner LM; Klugmann M; Ke YD
    Br J Pharmacol; 2019 Sep; 176(18):3649-3665. PubMed ID: 30817847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A short perspective on the long road to effective treatments for Alzheimer's disease.
    Reynolds DS
    Br J Pharmacol; 2019 Sep; 176(18):3636-3648. PubMed ID: 30657599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid precursor protein-mediated mitochondrial regulation and Alzheimer's disease.
    Lopez Sanchez MIG; van Wijngaarden P; Trounce IA
    Br J Pharmacol; 2019 Sep; 176(18):3464-3474. PubMed ID: 30471088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targeting of nuclear receptors, liver X and retinoid X receptors, for Alzheimer's disease.
    Fitz NF; Nam KN; Koldamova R; Lefterov I
    Br J Pharmacol; 2019 Sep; 176(18):3599-3610. PubMed ID: 30924124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.
    Nalivaeva NN; Turner AJ
    Br J Pharmacol; 2019 Sep; 176(18):3447-3463. PubMed ID: 30710367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging roles of microglial cathepsins in neurodegenerative disease.
    Lowry JR; Klegeris A
    Brain Res Bull; 2018 May; 139():144-156. PubMed ID: 29454581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-angle development of therapeutic methods for Alzheimer's disease.
    Hoshi M
    Br J Pharmacol; 2021 Feb; 178(4):770-783. PubMed ID: 32592177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of IL-17 rescues amyloid-β-induced neuroinflammation and memory impairment.
    Cristiano C; Volpicelli F; Lippiello P; Buono B; Raucci F; Piccolo M; Iqbal AJ; Irace C; Miniaci MC; Perrone Capano C; Calignano A; Mascolo N; Maione F
    Br J Pharmacol; 2019 Sep; 176(18):3544-3557. PubMed ID: 30673121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease.
    Sobue A; Komine O; Hara Y; Endo F; Mizoguchi H; Watanabe S; Murayama S; Saito T; Saido TC; Sahara N; Higuchi M; Ogi T; Yamanaka K
    Acta Neuropathol Commun; 2021 Jan; 9(1):1. PubMed ID: 33402227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets.
    Herman FJ; Simkovic S; Pasinetti GM
    Br J Pharmacol; 2019 Sep; 176(18):3558-3584. PubMed ID: 30632147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and molecular influencers of neuroinflammation in Alzheimer's disease: Recent concepts & roles.
    Ghosh P; Singh R; Ganeshpurkar A; Pokle AV; Singh RB; Singh SK; Kumar A
    Neurochem Int; 2021 Dec; 151():105212. PubMed ID: 34656693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.